Bachelor in Bioinnovation

Mahidol University in Bangkok is one of Thailand's most respected research universities, established in 1943 and widely recognized for excellence in health sciences, medicine and related fields. Serving over 28,000 students, Mahidol combines world-class teaching with extensive clinical and research facilities, including university hospitals and advanced laboratories. The university fosters interdisciplinary study across science, engineering, social sciences and the humanities.

Research and practical training are central to Mahidol's approach, with strong links to hospitals, research centers and industry partners that give students hands-on experience and exposure to cutting-edge projects. International exchange programs and collaborations expand learning horizons, and a broad network of faculty experts supports graduate and doctoral research. The campus culture encourages social responsibility and global engagement.

Bangkok offers a dynamic urban environment with rich cultural life and numerous professional opportunities for internships and part-time work. Mahidol's comprehensive student services, language support and international offices help newcomers adapt and thrive. Prospective international students can expect rigorous academics, extensive research resources and a community committed to health, innovation and societal impact across 26 principal program areas.

The Bachelor in Bioinnovation at Mahidol University is a 4-year degree for high school graduates who want to study in English. This program helps students learn about bioinnovation and its applications.

The curriculum includes subjects like biotechnology and biomedical engineering, helping students develop skills in research and development. Students also get hands-on experience in labs and projects.

Graduates can work as research assistants, biomedical engineers, or quality control specialists in industries like pharmaceuticals or healthcare. They can also work as science writers or consultants for companies that develop new medical devices.